Trademark: 90157600
Word
EKSTERMED
Status
Pending
Status Code
734
Status Date
Wednesday, October 18, 2023
Serial Number
90157600
Mark Type
3000
Filing Date
Thursday, September 3, 2020
Published for Opposition
Tuesday, February 23, 2021

Trademark Owner History
Teikoku Pharma USA, Inc. - Owner At Publication

Classifications
5 Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions
3 Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; non-medicated soaps for personal use; perfumery; essential oils; hair lotions
The mark consists of the word, "EksterMed" with "Ekster" in dark blue and "Med" in lighter blue. Above the wording is a design consisting of seventy-five small circles lined both horizontally and vertically, forming a shape of a plus symbol. The size of the circles is large in the inner part and dark blue and the circles become light blue and smaller toward the outer part.
The color(s) light blue and dark blue is/are claimed as a feature of the mark.

Trademark Events
Oct 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 18, 2023
Sou Extension 5 Granted
Oct 16, 2023
Sou Extension 5 Filed
Oct 16, 2023
Sou Teas Extension Received
Apr 19, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 17, 2023
Sou Extension 4 Granted
Apr 17, 2023
Sou Extension 4 Filed
Apr 17, 2023
Sou Teas Extension Received
Oct 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 17, 2022
Sou Extension 3 Granted
Oct 17, 2022
Sou Extension 3 Filed
Oct 17, 2022
Sou Teas Extension Received
Apr 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 15, 2022
Sou Extension 2 Granted
Apr 15, 2022
Sou Extension 2 Filed
Apr 15, 2022
Sou Teas Extension Received
Oct 27, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2021
Sou Extension 1 Granted
Oct 18, 2021
Sou Extension 1 Filed
Oct 25, 2021
Case Assigned To Intent To Use Paralegal
Oct 18, 2021
Sou Teas Extension Received
Apr 20, 2021
Noa E-Mailed - Sou Required From Applicant
Feb 23, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 23, 2021
Published For Opposition
Feb 3, 2021
Notification Of Notice Of Publication E-Mailed
Jan 15, 2021
Approved For Pub - Principal Register
Jan 14, 2021
Examiner's Amendment Entered
Jan 14, 2021
Assigned To Lie
Jan 13, 2021
Notification Of Examiners Amendment E-Mailed
Jan 13, 2021
Examiners Amendment E-Mailed
Jan 13, 2021
Examiners Amendment -Written
Jan 8, 2021
Assigned To Examiner
Oct 9, 2020
Notice Of Design Search Code E-Mailed
Oct 8, 2020
New Application Office Supplied Data Entered
Sep 7, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24